{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T23:33:53Z","timestamp":1781912033417,"version":"3.54.5"},"reference-count":60,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T00:00:00Z","timestamp":1750204800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Metabolic dysfunction-associated fatty liver disease (MAFLD) has recently replaced nonalcoholic fatty liver disease (NAFLD) as a term that more accurately describes its pathogenesis. <jats:italic>Helicobacter pylori<\/jats:italic> (<jats:italic>H. pylori<\/jats:italic>), a bacterium that infects over half the world\u2019s population, has been increasingly linked to various extragastric diseases. However, the impact of <jats:italic>H. pylori<\/jats:italic> on MAFLD in the Chinese population remains unexplored.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A retrospective cross-sectional study was conducted, encompassing 5619 participants from the First Affiliated Hospital of Wenzhou Medical University, spanning from April 2016 to August 2017. Detection of <jats:italic>H. pylori<\/jats:italic> was achieved through the <jats:sup>13<\/jats:sup>C urea breath test or gastric biopsies with histochemical staining. Fatty liver was primarily diagnosed via ultrasound and assessed alongside metabolic indicators to confirm MAFLD. Logistic regression was utilized to evaluate the association between <jats:italic>H. pylori<\/jats:italic> and MAFLD.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>No significant correlation between <jats:italic>H. pylori<\/jats:italic> infection and MAFLD was found in the overall population through either univariate (OR=1.136, 95%CI 0.995-1.297, p=0.059) or multivariate logistic regression analysis (OR=1.036, 95%CI 0.877-1.224, p=0.675). However, subgroup analysis revealed a significant association in overweight individuals (BMI \u2265 23 kg\/m<jats:sup>2<\/jats:sup>) within the MAFLD group (51.2% vs. 35.5%, p=0.002), a pattern not observed in the non-MAFLD group (47.7% vs. 45.4%, p=0.126). This association persisted after adjusting for confounders (OR=1.957, 95%CI 1.176-3.256, p=0.010).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Overweight individuals with MAFLD have a higher prevalence of <jats:italic>H. pylori<\/jats:italic> infection than their lean counterparts. This suggests a detrimental cycle between overweight status and <jats:italic>H. pylori<\/jats:italic> infection in MAFLD patients, potentially exacerbating metabolic deterioration. Therefore, eradication of <jats:italic>H. pylori<\/jats:italic> infection may have positive implications for reducing the incidence rate of overweight MAFLD.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fcimb.2025.1565298","type":"journal-article","created":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T05:47:38Z","timestamp":1750225658000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Overweight and Helicobacter pylori infection: a correlation in metabolic dysfunction-associated fatty liver disease"],"prefix":"10.3389","volume":"15","author":[{"given":"Xu","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayue","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kejia","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zixuan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yidan","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kehan","family":"Mei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yihan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jialei","family":"Min","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yilin","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zaisheng","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengcun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,6,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"5556354","DOI":"10.1155\/2021\/5556354","article-title":"NAFLD and infection, a nuanced relationship","volume":"2021","author":"Adenote","year":"2021","journal-title":"Can. J. Gastroenterol. Hepatol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/s13148-020-00917-2","article-title":"Circulating histone signature of human lean metabolic-associated fatty liver disease (MAFLD)","volume":"12","author":"Buzova","year":"2020","journal-title":"Clin. Epigen."},{"key":"B3","doi-asserted-by":"publisher","first-page":"8040262","DOI":"10.1155\/2018\/8040262","article-title":"Association between helicobacter pylori infection and nonalcoholic fatty liver disease: A single-center clinical study","volume":"2018","author":"Cai","year":"2018","journal-title":"Gastroenterol. Res. Pract."},{"key":"B4","doi-asserted-by":"publisher","first-page":"2691","DOI":"10.1210\/clinem\/dgac321","article-title":"Global prevalence and clinical characteristics of metabolic-associated fatty liver disease: A meta-analysis and systematic review of 10 739\u2013607 individuals","volume":"107","author":"Chan","year":"2022","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"B5","doi-asserted-by":"publisher","first-page":"10746","DOI":"10.1038\/s41598-018-28792-1","article-title":"A community-based study on the association between Helicobacter pylori Infection and obesity","volume":"8","author":"Chen","year":"2018","journal-title":"Sci. Rep."},{"key":"B6","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1007\/s12072-021-10147-0","article-title":"The metabolic profiles and body composition of lean metabolic associated fatty liver disease","volume":"15","author":"Cheng","year":"2021","journal-title":"Hepatol. Int."},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.844954","article-title":"Non-alcoholic\/metabolic-associated fatty liver disease and helicobacter pylori additively increase the risk of arterial stiffness","volume":"9","author":"Choi","year":"2022","journal-title":"Front. Med. (Lausanne)."},{"key":"B8","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1097\/MEG.0b013e3282efa4f2","article-title":"Identification of Helicobacter species by 16S rDNA PCR and sequence analysis in human liver samples from patients with various etiologies of benign liver diseases","volume":"20","author":"Cindoruk","year":"2008","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1053\/j.gastro.2009.01.073","article-title":"Helicobacter pylori in health and disease","volume":"136","author":"Cover","year":"2009","journal-title":"Gastroenterology"},{"key":"B10","doi-asserted-by":"publisher","first-page":"436","DOI":"10.3350\/cmh.2024.0109","article-title":"Global prevalence of metabolic dysfunction-associated fatty liver disease-related hepatocellular carcinoma: A systematic review and meta-analysis","volume":"30","author":"Crane","year":"2024","journal-title":"Clin. Mol. Hepatol."},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0218274","article-title":"Exploring the impact of Helicobacter pylori on gut microbiome composition","volume":"14","author":"Dash","year":"2019","journal-title":"PloS One"},{"key":"B12","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.metabol.2017.03.013","article-title":"Non-alcoholic fatty liver disease: An update with special focus on the role of gut microbiota","volume":"71","author":"Doulberis","year":"2017","journal-title":"Metabolism"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1111\/hel.12454","article-title":"Review: Impact of Helicobacter pylori on Alzheimer\u2019s disease: What do we know so far","volume":"23","author":"Doulberis","year":"2017","journal-title":"Helicobacter"},{"key":"B14","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1038\/s41575-022-00635-5","article-title":"Metabolic (dysfunction)-associated fatty liver disease in individuals of normal weight","volume":"19","author":"Eslam","year":"2022","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","article-title":"A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement","volume":"73","author":"Eslam","year":"2020","journal-title":"J. Hepatol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1053\/j.gastro.2019.11.312","article-title":"MAFLD: A consensus-driven proposed nomenclature for metabolic associated fatty liver disease","volume":"158","author":"Eslam","year":"2020","journal-title":"Gastroenterology"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2018.00073","article-title":"Helicobacter pylori infection is not associated with non-alcoholic fatty liver disease: A cross-sectional study in China","volume":"9","author":"Fan","year":"2018","journal-title":"Front. Microbiol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1111\/hepr.13973","article-title":"Impact of non-obese metabolic dysfunction-associated fatty liver disease on risk factors for the recurrence of esophageal squamous cell carcinoma treated with endoscopic submucosal dissection: A multicenter study","volume":"54","author":"Fukunaga","year":"2024","journal-title":"Hepatol. Res."},{"key":"B19","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1016\/j.cellsig.2012.12.011","article-title":"Ahsg-fetuin blocks the metabolic arm of insulin action through its interaction with the 95-kD beta-subunit of the insulin receptor","volume":"25","author":"Goustin","year":"2013","journal-title":"Cell Signal."},{"key":"B20","doi-asserted-by":"publisher","first-page":"3887","DOI":"10.3390\/jcm9123887","article-title":"Extra-gastric manifestations of helicobacter pylori infection","volume":"9","author":"Gravina","year":"2020","journal-title":"J. Clin. Med."},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0260994","article-title":"The association between Helicobacter pylori with nonalcoholic fatty liver disease assessed by controlled attenuation parameter and other metabolic factors","volume":"16","author":"Han","year":"2021","journal-title":"PloS One"},{"key":"B22","doi-asserted-by":"publisher","first-page":"171","DOI":"10.5152\/tjg.2022.21467","article-title":"Helicobacter pylori infection and non-alcoholic fatty liver disease: A systematic review and meta-analysis","volume":"33","author":"Heydari","year":"2022","journal-title":"Turk. J. Gastroenterol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1042\/CS20120542","article-title":"Fetuin-A mRNA expression is elevated in NASH compared with NAFL patients","volume":"125","author":"Kahraman","year":"2013","journal-title":"Clin. Sci. (Lond)."},{"key":"B24","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/0022-4804(82)90012-9","article-title":"Study of function and maturation of monocytes in morbidly obese individuals","volume":"33","author":"Krishnan","year":"1982","journal-title":"J. Surg. Res."},{"key":"B25","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1038\/s41575-021-00523-4","article-title":"Advancing the global public health agenda for NAFLD: a consensus statement","volume":"19","author":"Lazarus","year":"2022","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/j.cgh.2021.11.038","article-title":"An observational data meta-analysis on the differences in prevalence and risk factors between MAFLD vs NAFLD","volume":"21","author":"Lim","year":"2023","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.764472","article-title":"Association between helicobacter pylori infection and non-alcoholic fatty liver disease, hepatic adipose deposition and stiffness in Southwest China","volume":"8","author":"Liu","year":"2021","journal-title":"Front. Med. (Lausanne)."},{"key":"B28","doi-asserted-by":"publisher","first-page":"154955","DOI":"10.1016\/j.metabol.2021.154955","article-title":"Metabolic dysfunction-associated fatty liver disease and the risk of 24 specific cancers","volume":"127","author":"Liu","year":"2022","journal-title":"Metabolism"},{"key":"B29","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1136\/gutjnl-2012-302084","article-title":"Management of Helicobacter pylori infection\u2013the Maastricht IV\/Florence Consensus Report","volume":"61","author":"Malfertheiner","year":"2012","journal-title":"Gut"},{"key":"B30","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1136\/gutjnl-2016-312288","article-title":"Management of Helicobacter pylori infection-the Maastricht V\/Florence Consensus Report","volume":"66","author":"Malfertheiner","year":"2017","journal-title":"Gut"},{"key":"B31","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.metabol.2019.04.012","article-title":"Association between Helicobacter pylori infection and risk of nonalcoholic fatty liver disease: An updated meta-analysis","volume":"96","author":"Mantovani","year":"2019","journal-title":"Metabolism"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1016\/S0140-6736(84)91816-6","article-title":"Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration","volume":"1","author":"Marshall","year":"1984","journal-title":"Lancet"},{"key":"B33","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1046\/j.1467-789x.2001.00025.x","article-title":"Obesity and immune function relationships","volume":"2","author":"Marti","year":"2001","journal-title":"Obes. Rev."},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.639856","article-title":"Gut microbiota: the missing link between helicobacter pylori infection and metabolic disorders","volume":"12","author":"Martin-Nunez","year":"2021","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"B35","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1111\/j.1523-5378.2012.00967.x","article-title":"Observation of gastric mucosa in Bangladesh, the country with the lowest incidence of gastric cancer, and Japan, the country with the highest incidence","volume":"17","author":"Matsuhisa","year":"2012","journal-title":"Helicobacter"},{"key":"B36","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1111\/hepr.14010","article-title":"Impact of metabolic dysfunction-associated fatty liver disease on the incidence of Helicobacter pylori-negative gastric cancer","volume":"54","author":"Nakane","year":"2024","journal-title":"Hepatol. Res."},{"key":"B37","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1097\/MEG.0000000000001398","article-title":"Association between Helicobacter pylori infection and nonalcoholic fatty liver disease: a systemic review and meta-analysis","volume":"31","author":"Ning","year":"2019","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1038\/nm.2851","article-title":"Fetuin-A acts as an endogenous ligand of TLR4 to promote lipid-induced insulin resistance","volume":"18","author":"Pal","year":"2012","journal-title":"Nat. Med."},{"key":"B39","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1111\/j.1365-2141.1980.tb01188.x","article-title":"Polymorphonuclear (PMN) function after small intestinal shunt operation for morbid obesity","volume":"44","author":"Palmblad","year":"1980","journal-title":"Br. J. Haematol."},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1111\/hel.2019.24.issue-3","article-title":"Helicobacter pylori infection and nonalcoholic fatty liver disease: Time for large clinical trials evaluating eradication therapy","volume":"24","author":"Polyzos","year":"2019","journal-title":"Helicobacter"},{"key":"B41","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1590\/S0004-28032014000300017","article-title":"Effect of Helicobacter pylori eradication on hepatic steatosis, NAFLD fibrosis score and HSENSI in patients with nonalcoholic steatohepatitis: a MR imaging-based pilot open-label study","volume":"51","author":"Polyzos","year":"2014","journal-title":"Arq. Gastroenterol."},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.14309\/ctg.0000000000000323","article-title":"Diagnostic performance of fibroTouch ultrasound attenuation parameter and liver stiffness measurement in assessing hepatic steatosis and fibrosis in patients with nonalcoholic fatty liver disease","volume":"12","author":"Qu","year":"2021","journal-title":"Clin. Transl. Gastroenterol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.virol.2005.09.058","article-title":"Revisiting the liver in human yellow fever: virus-induced apoptosis in hepatocytes associated with TGF-beta, TNF-alpha and NK cells activity","volume":"345","author":"Quaresma","year":"2006","journal-title":"Virology"},{"key":"B44","doi-asserted-by":"publisher","first-page":"2350","DOI":"10.1210\/jc.2007-2057","article-title":"Leptin and ghrelin in relation to Helicobacter pylori status in adult males","volume":"93","author":"Roper","year":"2008","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1172\/JCI118891","article-title":"Identification of targets of leptin action in rat hypothalamus","volume":"98","author":"Schwartz","year":"1996","journal-title":"J. Clin. Invest."},{"key":"B46","first-page":"51","article-title":"Study and comparison of metabolic profile of lean and obese subjects with non alcoholic fatty liver disease","volume":"68","author":"Shah","year":"2020","journal-title":"J. Assoc. Phys. India."},{"key":"B47","doi-asserted-by":"publisher","first-page":"227","DOI":"10.2337\/diabetes.50.2.227","article-title":"Ghrelin, an endogenous growth hormone secretagogue, is a novel orexigenic peptide that antagonizes leptin action through the activation of hypothalamic neuropeptide Y\/Y1 receptor pathway","volume":"50","author":"Shintani","year":"2001","journal-title":"Diabetes"},{"key":"B48","doi-asserted-by":"publisher","first-page":"154433","DOI":"10.1016\/j.metabol.2020.154433","article-title":"MAFLD and risk of CKD","volume":"115","author":"Sun","year":"2021","journal-title":"Metabolism"},{"key":"B49","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1532\/IJH97.06180","article-title":"Overview: Helicobacter pylori and extragastric disease","volume":"84","author":"Suzuki","year":"2006","journal-title":"Int. J. Hematol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1111\/cdd.2016.17.issue-7","article-title":"Association between Helicobacter pylori infection and metabolic syndrome: a systematic review and meta-analysis","volume":"17","author":"Upala","year":"2016","journal-title":"J. Dig. Dis."},{"key":"B51","doi-asserted-by":"publisher","first-page":"266","DOI":"10.3109\/08941939.2016.1149640","article-title":"Fetuin A is a predictor of liver fat in preoperative patients with nonalcoholic fatty liver disease","volume":"29","author":"von Loeffelholz","year":"2016","journal-title":"J. Invest. Surg."},{"key":"B52","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s12876-022-02148-6","article-title":"Helicobacter pylori infection is not an independent risk factor of non-alcoholic fatty liver disease in China","volume":"22","author":"Wang","year":"2022","journal-title":"BMC Gastroenterol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"777","DOI":"10.14218\/JCTH.2022.00154","article-title":"Comparison of clinical characteristics and outcomes of MAFLD and NAFLD in Chinese health examination populations","volume":"11","author":"Xu","year":"2023","journal-title":"J. Clin. Transl. Hepatol."},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0177249","article-title":"Association between the hyperuricemia and nonalcoholic fatty liver disease risk in a Chinese population: A retrospective cohort study","volume":"12","author":"Yang","year":"2017","journal-title":"PloS One"},{"key":"B55","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"B56","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1002\/hep.32499","article-title":"Are there outcome differences between NAFLD and metabolic-associated fatty liver disease","volume":"76","author":"Younossi","year":"2022","journal-title":"Hepatology"},{"key":"B57","doi-asserted-by":"publisher","first-page":"2096","DOI":"10.3390\/ijerph19042096","article-title":"Prevalence and risk factors of metabolic-associated fatty liver disease among 73,566 individuals in Beijing, China","volume":"19","author":"Yuan","year":"2022","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"B58","doi-asserted-by":"publisher","first-page":"671","DOI":"10.21037\/hbsn-21-546","article-title":"Associations between metabolic dysfunction-associated fatty liver disease and extrahepatic cancers: a cohort in China","volume":"12","author":"Yuan","year":"2023","journal-title":"Hepatobil. Surg. Nutr."},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1111\/hel.2019.24.issue-3","article-title":"Association between Helicobacter pylori infection and nonalcoholic fatty liver disease: A systematic review and meta-analysis of observational studies","volume":"24","author":"Zhou","year":"2019","journal-title":"Helicobacter"},{"key":"B60","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1002\/hep.31150","article-title":"Epidemiological features of NAFLD from 1999 to 2018 in China","volume":"71","author":"Zhou","year":"2020","journal-title":"Hepatology"}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2025.1565298\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T05:47:39Z","timestamp":1750225659000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2025.1565298\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,18]]},"references-count":60,"alternative-id":["10.3389\/fcimb.2025.1565298"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2025.1565298","relation":{},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,18]]},"article-number":"1565298"}}